CBPO Key Statistics, Chart & Performance
The current stock price of CBPO is 119.99 null. In the past month the price increased by 2.25%. In the past year, price increased by 12.37%.
CBPO Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to CBPO. When comparing the yearly performance of all stocks, CBPO is a bad performer in the overall market: 77.21% of all stocks are doing better.
CBPO Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CBPO. While CBPO has a great health rating, its profitability is only average at the moment.
CBPO Financial Highlights
Over the last trailing twelve months CBPO reported a non-GAAP Earnings per Share(EPS) of 3.99. The EPS decreased by -6.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 29.04% | ||
| ROA | 7.12% | ||
| ROE | 7.71% | ||
| Debt/Equity | 0 |
CBPO Forecast & Estimates
CBPO Ownership
About CBPO
Company Profile
China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Company Info
China Biologic Produ
18TH FL JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD CHAOYANG DISTRICT
BEIJING F4 100125
CEO: Joseph Chow
Phone: 86-10-6598-3111
China Biologic Produ / CBPO FAQ
Can you describe the business of China Biologic Produ?
China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Can you provide the latest stock price for China Biologic Produ?
The current stock price of CBPO is 119.99 null. The price increased by 1.68% in the last trading session.
Does CBPO stock pay dividends?
CBPO does not pay a dividend.
What is the ChartMill technical and fundamental rating of CBPO stock?
CBPO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is China Biologic Produ (CBPO) stock traded?
CBPO stock is listed on the Nasdaq exchange.
Can you provide the market cap for China Biologic Produ?
China Biologic Produ (CBPO) has a market capitalization of 4.72B null. This makes CBPO a Mid Cap stock.